Amlodipine, atorvastatin
Sold as Caduet
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 1
- Registrations
- 6
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Viatris Healthcare (Pty) Ltd | Caduet | 5 mg/10 mg, 5 mg/20 mg, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, 10 mg/80 mg | A390326, A390327, A390330, A390331, A390332, A390333 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Caduet 5 mg/10 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg ATORVASTATIN 10,0 mg | 5 mg/10 mg | A390326A39/7.0/0326 | Registered | Not determined | None |
| Caduet 5 mg/20 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 5,0 mg ATORVASTATIN 20,0 mg | 5 mg/20 mg | A390327A39/7.0/0327 | Registered | Not determined | None |
| Caduet 10 mg/10 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg ATORVASTATIN 10,0 mg | 10 mg/10 mg | A390330A39/7.0/0330 | Registered | Not determined | None |
| Caduet 10 mg/20 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg ATORVASTATIN 20,0 mg | 10 mg/20 mg | A390331A39/7.0/0331 | Registered | Not determined | None |
| Caduet 10 mg/40 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg ATORVASTATIN 40,0 mg | 10 mg/40 mg | A390332A39/7.0/0332 | Registered | Not determined | None |
| Caduet 10 mg/80 MG EACH TABLET CONTAINS AMLODIPINE BESYLATE EQUIVALENT TO AMLODIPINE 10,0 mg ATORVASTATIN 80,0 mg | 10 mg/80 mg | A390333A39/7.0/0333 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Atorvastatin
Consolidated Schedules 06 July 2026, line 5376
S3: Amlodipine
Consolidated Schedules 06 July 2026, line 3138
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.